Hjortsberg, C. (1999) “Cost-effectiveness Analysis of Pegylated-liposomal Doxorubicin and Liposomal Daunorubicin Treatments in Patients with Kaposi’s Sarcoma”, Acta Oncologica, 38(8), pp. 1063–1067. doi: 10.1080/028418699432374.